📊 Score Breakdown
Offering Ability
40
Cash Runway
0
Float Risk
90
Warrant Exposure
15
Convertible Debt—
🌦️ Dilution Forecast
🌥️
Advisory
Moderate dilution signals present
34%
🔁 Convertible Conversion
40%
• Significant convertible debt: 28% potential dilution
• Elevated convertible risk (60/100)
🔄 Reverse Split
30%
• 50-day avg $1.67 approaching $1 threshold
📉 Score Deterioration
25%
• Score increased 14 points recently (worsening)
💹 Market Data
Market Cap$176.79M
Shares Outstanding124.50M
Float14.07M
Cash$105.96M
Debt$58.38M
Short InterestN/A
🏛 Institutional Holdings
QoQ: ↓ 18.4% shares (2025Q4 vs prior)
78 institutional holders · 28.30M shares
#1
Propel Bio Management, LLC
4.12M shares
#2
ADAGE CAPITAL PARTNERS GP, L.L.C.
2.81M shares
#3
RTW INVESTMENTS, LP
2.51M shares
+ 17 more holders Sign up free to view →
📉 Short Interest
Short Interest7.48M
Days to Cover4.3
% of Float53.2%
FINRA data as of May 15, 2026
📁 Recent SEC Activity
xbrl
XBRL CONVERTIBLE
Dec 31, 2023
xbrl
XBRL WARRANT
Dec 31, 2022
Full SEC filing analysis available with free account →
📰 Recent News
No recent news
🔬 More Research for MIST
📊 MIST FDA Catalyst Timeline & Biotech Grade — BiotechSigns
📡 MIST Signal Convergence & Dark Pool Activity — StonkWhisper
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.